Physician profile
Jill A Johnson
NPI 1780636100
$1,217.63
in general payments reported to CMS, 2019-2025
8 companies · $377 in 2025
The $377 reported for 2025 was more than what 95% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $215 · 2024: $626 · 2025: $377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,148 · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,147.64 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $530.51 | 2023-2025 | Imfinzi |
| Novartis Pharmaceuticals Corporation | $406.59 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $107.26 | 2024-2025 | Opdivo, Krazati, Opdualag |
| Pfizer INC. | $60.44 | 2024-2025 | |
| Kite Pharma, INC. | $40.94 | 2025 | Yescarta |
| Biosense Webster, INC. | $33.01 | 2024 | Carto 3 |
| Merck Sharp & Dohme LLC | $24.49 | 2024 | Keytruda |
| Sobi, INC | $14.39 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.